Form 4: Inovio Pharmaceuticals Director Exercises Stock Options

Director Roger D. Dansey exercised stock options to acquire 1,000 shares of Inovio Pharmaceuticals common stock on May 13, 2024.

Summary

• On May 13, 2024, Roger D. Dansey, a director of Inovio Pharmaceuticals, exercised restricted stock units.
• This transaction resulted in the acquisition of 1,000 shares of common stock.
• Following the transaction, Dansey directly owns 4,583 shares of Inovio Pharmaceuticals.
• The restricted stock units vested in three tranches of 1,000 shares each on May 13, 2022, May 13, 2023, and May 13, 2024.
• The reported figures reflect a 1-for-12 reverse stock split that Inovio Pharmaceuticals implemented on January 24, 2024.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a routine transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders, allowing investors to monitor their investment.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the increase in the number of outstanding shares.

Key Dates